113 related articles for article (PubMed ID: 8146068)
1. Effect of early exposure of flutamide on subsequent growth of transplantable rat prostatic tumor (dunning R-3327).
Lee SZ; Sato N; Suzuki H; Watabe Y; Masai M; Shimazaki J
Prostate; 1994 Apr; 24(4):197-203. PubMed ID: 8146068
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen flutamide on the Dunning R3327 prostatic carcinoma in rats.
Zaccheo T; Giudici D; di Salle E
Endocr Relat Cancer; 1999 Sep; 6(3):429-35. PubMed ID: 10516856
[TBL] [Abstract][Full Text] [Related]
3. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
Zaccheo T; Giudici D; di Salle E
Prostate; 1997 Feb; 30(2):85-91. PubMed ID: 9051146
[TBL] [Abstract][Full Text] [Related]
4. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
Zaccheo T; Giudici D; Panzeri A; di Salle E
Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
[TBL] [Abstract][Full Text] [Related]
5. Effects of estrogen on growth of androgen-responsive rat prostatic tumor (R 3327).
Furuya Y; Sato N; Watabe Y; Shimazaki J
Endocrinol Jpn; 1991 Feb; 38(1):67-73. PubMed ID: 1915114
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.
Redding TW; Schally AV
Prostate; 1985; 6(3):219-32. PubMed ID: 3157927
[TBL] [Abstract][Full Text] [Related]
7. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
Tomura A; Kuroiwa S; Okada M; Abe F
Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
9. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE
Prostate; 1991; 18(3):215-27. PubMed ID: 1850515
[TBL] [Abstract][Full Text] [Related]
10. Effect of adrenalectomy, flutamide, and leuprolide on the growth of the Dunning rat R-3327 prostatic carcinoma.
Kung TT; Mingo GG; Siegel MI; Watnick AS
Prostate; 1988; 12(4):357-63. PubMed ID: 3134647
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
Donn F; Becker H; Klosterhalfen H; Klein H
Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
[TBL] [Abstract][Full Text] [Related]
13. An inhibitory effect of TZP-4238 on the growth of androgen-sensitive rat prostatic tumor (Dunning R3327).
Ichikawa T; Akimoto S; Shimazaki J
Endocr J; 1993 Aug; 40(4):425-30. PubMed ID: 7522799
[TBL] [Abstract][Full Text] [Related]
14. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
Furr BJ; Tucker H
Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
[TBL] [Abstract][Full Text] [Related]
15. Action of prolactin in regressing prostate: independent of action mediated by androgen receptors.
Assimos D; Smith C; Lee C; Grayhack JT
Prostate; 1984; 5(6):589-95. PubMed ID: 6494057
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats.
Cook JC; Mullin LS; Frame SR; Biegel LB
Toxicol Appl Pharmacol; 1993 Apr; 119(2):195-204. PubMed ID: 8480329
[TBL] [Abstract][Full Text] [Related]
17. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
Fleshner NE; Trachtenberg J
J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
[TBL] [Abstract][Full Text] [Related]
18. Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.
Stone NN; Clejan SJ
J Androl; 1991; 12(6):376-80. PubMed ID: 1722793
[TBL] [Abstract][Full Text] [Related]
19. Flutamide. Mechanism of action of a new nonsteroidal antiandrogen.
Sufrin G; Coffey DS
Invest Urol; 1976 May; 13(6):429-34. PubMed ID: 1270239
[TBL] [Abstract][Full Text] [Related]
20. Large Shionogi tumors lose their responsiveness to flutamide treatment.
Chen C; Poulin R; Labrie F
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):489-94. PubMed ID: 8918974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
